Serum calcium, phosphorus, intact PTH, and activated vitamin D requirements (paricalcitol) were similar in the control and intervention arms through the trial (Table 2), and no episodes of sustained hypercalcemia occurred in either group during the study (Table 2, see RawData S1). This evidence concerns the gene PTH and hypercalcemia disease.